Skip to main content
Themis Medicare Ltd. logo

Themis Medicare Ltd. — Investor Relations & Filings

Ticker · THEMISMED ISIN · INE083B01024 LEI · 335800LHRDVIKH69AF42 BSE.NS Manufacturing
Open in API
Filings indexed 715 across all filing types
Latest filing 2024-07-22 AGM Information
Country IN India
Listing BSE.NS THEMISMED

About Themis Medicare Ltd.

https://www.themismedicare.com/

Themis Medicare Ltd. is a research-driven pharmaceutical organization specializing in the development, manufacture, and marketing of a diverse range of therapeutic products. The company focuses on high-value segments including pain management, anesthesia, critical care, anti-infectives, and oncology. Its core competencies lie in the production of Active Pharmaceutical Ingredients (APIs) and complex finished dosage formulations, particularly injectables. Themis Medicare maintains a strong emphasis on Research and Development, operating state-of-the-art facilities that adhere to international quality standards such as WHO-GMP. Through strategic partnerships and a robust supply chain, the company serves both domestic and international markets, providing specialized medical solutions for hospital-based care and chronic disease management. Its portfolio includes proprietary delivery systems and differentiated generic products designed to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Updates
AGM Information Classification · 100% confidence The document is titled as proceedings of the 54th Annual General Meeting (AGM) of Themis Medicare Limited held on 22nd July 2024. It details the date, time, venue, attendance, quorum, and the items discussed and approved during the meeting, including adoption of financial statements, appointment of directors, dividend declaration, and remuneration approvals. It also mentions the voting process and that the resolutions were passed with requisite majority. The document is a detailed summary of the AGM proceedings rather than the full Annual Report or financial statements themselves. It is not a simple announcement or notice but a report of the meeting's proceedings. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (7766 characters) supports it being a full proceedings report rather than a brief announcement.
2024-07-22 English
Cessation
Board/Management Information Classification · 95% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) regarding the cessation of office of an Independent Director and the appointment of a new Non-Executive Independent Director. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about changes in the board of directors or senior management. The content focuses on changes in the company's board composition, specifically the end of term and appointment of directors, without any financial data or report attached. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short and does not contain financial statements or detailed reports, so it is not an Annual Report or similar. Hence, the classification is MANG with high confidence.
2024-07-22 English
Shareholders meeting
Regulatory Filings
2024-07-22 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is titled 'Proceedings of the 54th Annual General Meeting of Themis Medicare Limited held on 22nd July, 2024.' It details the date, time, venue, attendance, quorum, and the items discussed and approved during the AGM. It includes information about voting methods, resolutions passed, and acknowledgments by the Chairman. The document does not contain full financial statements or detailed financial analysis but summarizes the meeting proceedings and resolutions. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting. The document length (7674 characters) is sufficient to contain detailed proceedings rather than a brief announcement. Therefore, the correct classification is AGM Information (AGM-R).
2024-07-22 English
Board Meeting — THEMIS MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 26-Jul-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for t…
Regulatory Filings
2024-07-16 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the scheduled date of a Board Meeting to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2024. It also mentions the closure of the trading window for insiders in compliance with SEBI regulations. The document is dated July 16, 2024, and is signed by the Company Secretary & Compliance Officer. The content is an announcement of an upcoming board meeting and trading window closure, not the financial results report itself. The document length is short (2226 characters) and it does not contain any financial data or detailed report. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a regulatory announcement about a board meeting and trading window closure, not the actual financial report or earnings release.
2024-07-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.